Parion Sciences Selected as 2014 Tibbetts Award Recipient by the Small Business Administration (SBA) June 19, 2014News & EventPaul Boucher Continue reading Parion Sciences Selected as 2014 Tibbetts Award Recipient by the Small Business Administration (SBA) →
Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories June 12, 2014News & EventPaul Boucher Continue reading Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories →
Parion Sciences Announces Senior Leadership and Organizational Changes June 2, 2014News & EventPaul Boucher Continue reading Parion Sciences Announces Senior Leadership and Organizational Changes →
Parion Sciences Receives FDA Acceptance of the Investigational New Drug Application for Clinical Testing of P-321 Ophthalmic Solution for the Treatment of Dry Eye Disease May 1, 2014News & EventPaul Boucher Continue reading Parion Sciences Receives FDA Acceptance of the Investigational New Drug Application for Clinical Testing of P-321 Ophthalmic Solution for the Treatment of Dry Eye Disease →
Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors April 30, 2014News & EventPaul Boucher Continue reading Parion Sciences Reacquires Rights to Epithelial Sodium Channel Inhibitors →
